NCT01687855
- Conditions
- Apnea, Dyssomnias, Nervous System Diseases, +10 more
- Locations
-
- The Tenth Hospital Affiliated to Tongji University Shanghai, Shanghai Municipality, China
Clinical trial condition
Sleep Disorders, Intrinsic
Explore clinical trials studying Sleep Disorders, Intrinsic. Study availability and eligibility vary by location and protocol.
4,492 public trials
665 recruiting studies
Sleep Disorders, Intrinsic trial results
Completed
Ergometer Training in Patients With OSA
NCT01457729
- Conditions
- Apnea, Dyssomnias, Nervous System Diseases, +7 more
- Locations
-
- Helios Klinik Hagen Ambrock Hagen, North Rhine-Westphalia, Germany
NCT01462409
- Conditions
- Apnea, Dyssomnias, Nervous System Diseases, +6 more
- Locations
-
- Helios Klinik Hagen Ambrock Hagen, North Rhine-Westphalia, Germany
NCT00692965
- Conditions
- Apnea, Blood-Borne Infections, Communicable Diseases, +22 more
- Locations
-
Not specified
NCT00107796
- Conditions
- Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +4 more
- Locations
-
- Robert Doekel, Jr., M.D. Birmingham, Alabama, United States
- Chris M. Makris, M.D. Birmingham, Alabama, United States
- Barbara Harris, Ph.D. Phoenix, Arizona, United States
- Derek Loewy, Ph.D. Tucson, Arizona, United States
NCT01332175
- Conditions
- Apnea, Dyssomnias, Nervous System Diseases, +7 more
- Locations
-
- Cantonal Hospital Munsterlingen, Departement of Internal Medicine, Pulmonary Division Münsterlingen, Switzerland
- University Hospital Zurich, Pulmonary Division Zurich, Switzerland
- Churchill Hospital, Oxford Centre for Respiratory Medicine Oxford, United Kingdom
NCT00867893
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States
Completed
To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary Insomnia
NCT00426816
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +3 more
- Locations
-
- GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany
- GSK Investigational Site Cottbus, Brandenburg, Germany
- GSK Investigational Site Hamburg, Free and Hanseatic City of Hamburg, Germany
- GSK Investigational Site Schwerin, Mecklenburg-Vorpommern, Germany
NCT01655797
- Conditions
- Dyssomnias, Insomnia, Mental Disorders, +4 more
- Locations
-
- Uppsala University Uppsala, Sweden
Completed
A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia
NCT00551148
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Pfizer Investigational Site Glendale, Arizona, United States
- Pfizer Investigational Site Phenoix, Arizona, United States
- Pfizer Investigational Site Phoenix, Arizona, United States
- Pfizer Investigational Site Tucson, Arizona, United States